Alembic obtains FDA OK for generic Luxiq Foam
Betamethasone valerate foam is indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the scalp.
Alembic has received the Food and Drug Administration’s blessing for betamethasone valerate foam, 0.12%.
The medication is the generic of Norvium’s Luxiq Foam.
[Read more: Alembic intros generic Perforomist]
Betamethasone valerate foam, 0.12% is a medium potency topical corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses of the scalp.
[Read more: Alembic gets FDA tentative OK for generic Bosulif]